NucleoBio and PreCheck Health Services Announce Strategic Collaboration to Advance Non-Invasive Prostate Cancer Testing NucleoBio, Corp., a leading biotechnology innovator in precision oncology ...
India, March 23 -- Advances in cancer research are improving how doctors diagnose and monitor diseases. One emerging tool is ...
Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the ...
“Prostate cancer remains one of the most challenging cancers for men worldwide, highlighting the urgent need for more accurate and non-invasive diagnostic tools. We believe that securing this ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity ...
Millions of men are already blocking time on their calendars for college basketball's biggest month. ProCure Proton Therapy Center, located right here in Somerset, is asking them to add one more item ...
A new mobile prostate cancer screening bus will begin visiting neighborhoods this month, offering free screenings to raise awareness and promote early detection. The initiative, supported by the ...
* New urine biomarker test shows over 90% accuracy in detecting prostate cancer * Test works even when PSA levels appear normal * Biomarker levels drop after //surgery, confirming prostate origin ...
A know-how licensing agreement for a non-invasive electrochemical screening technology, based on research by Prof. A. L. Roy Vellaisamy, Chair Professor of Intelligent Systems in the School of Science ...
A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...
For decades, the story of prostate cancer screening has been dominated by three letters: P-S-A. The Prostate-Specific Antigen blood test is the first line of defense for millions of men. Yet, for all ...
Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center. The results are important because this could enable at-home ...